Blueprint Medicines
BPMC
#2370
Rank
NZ$10.70 B
Marketcap
$168.51
Share price
-0.55%
Change (1 day)
73.34%
Change (1 year)

Blueprint Medicines (BPMC) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$0.78 Billion

According to Blueprint Medicines 's latest financial reports the company's total debt is NZ$0.78 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Blueprint Medicines - Total debt on balance sheet (from 2014 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$0.52 B37.68%
2022-12-31NZ$0.38 B134.13%
2021-12-31NZ$0.16 B31.34%
2020-12-31NZ$0.12 B-12.83%
2019-12-31NZ$0.14 B553.78%
2018-12-31NZ$21.79 M-13.29%
2017-12-31NZ$25.13 M134.02%
2016-12-31NZ$10.73 M-34.87%
2015-12-31NZ$16.48 M42.89%
2014-12-31NZ$11.54 M231.24%
2013-12-31NZ$3.48 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$0.65 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.45 B-42.85%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.54 B 96.17%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA